LB892 LB892
2024 2024
LEGISLATURE OF NEBRASKA
ONE HUNDRED EIGHTH LEGISLATURE
SECOND SESSION
LEGISLATIVE BILL 892
Introduced by Bosn, 25.
Read first time Committee: Judiciary
1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to
2 amend sections 28-405 and 28-416, Revised Statutes Supplement, 2023;
3 to change provisions relating to controlled substances schedules; to
4 harmonize provisions; and to repeal the original sections.
5 Be it enacted by the people of the State of Nebraska,
-1-
LB892 LB892
2024 2024
1 Section 1. Section 28-405, Revised Statutes Supplement, 2023, is
2 amended to read:
3 28-405 The following are the schedules of controlled substances
4 referred to in the Uniform Controlled Substances Act, unless specifically
5 contained on the list of exempted products of the Drug Enforcement
6 Administration of the United States Department of Justice as the list
7 existed on January 31, 2022:
8 Schedule I
9 (a) Any of the following opiates, including their isomers, esters,
10 ethers, salts, and salts of isomers, esters, and ethers, unless
11 specifically excepted, whenever the existence of such isomers, esters,
12 ethers, and salts is possible within the specific chemical designation:
13 (1) Acetylmethadol;
14 (2) Allylprodine;
15 (3) Alphacetylmethadol, except levo-alphacetylmethadol which is also
16 known as levo-alpha-acetylmethadol, levomethadyl acetate, and LAAM;
17 (4) Alphameprodine;
18 (5) Alphamethadol;
19 (6) Benzethidine;
20 (7) Betacetylmethadol;
21 (8) Betameprodine;
22 (9) Betamethadol;
23 (10) Betaprodine;
24 (11) Clonitazene;
25 (12) Dextromoramide;
26 (13) Difenoxin;
27 (14) Diampromide;
28 (15) Diethylthiambutene;
29 (16) Dimenoxadol;
30 (17) Dimepheptanol;
31 (18) Dimethylthiambutene;
-2-
LB892 LB892
2024 2024
1 (19) Dioxaphetyl butyrate;
2 (20) Dipipanone;
3 (21) Ethylmethylthiambutene;
4 (22) Etonitazene;
5 (23) Etoxeridine;
6 (24) Furethidine;
7 (25) Hydroxypethidine;
8 (26) Ketobemidone;
9 (27) Levomoramide;
10 (28) Levophenacylmorphan;
11 (29) Morpheridine;
12 (30) Noracymethadol;
13 (31) Norlevorphanol;
14 (32) Normethadone;
15 (33) Norpipanone;
16 (34) Phenadoxone;
17 (35) Phenampromide;
18 (36) Phenomorphan;
19 (37) Phenoperidine;
20 (38) Piritramide;
21 (39) Proheptazine;
22 (40) Properidine;
23 (41) Propiram;
24 (42) Racemoramide;
25 (43) Trimeperidine;
26 (44) Alpha-methylfentanyl, N-(1-(alpha-methyl-beta-phenyl)ethyl-4-
27 piperidyl) propionanilide, 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)
28 piperidine;
29 (45) Tilidine;
30 (46) 3-Methylfentanyl, N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-
31 phenylpropanamide, its optical and geometric isomers, salts, and salts of
-3-
LB892 LB892
2024 2024
1 isomers;
2 (47) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical
3 isomers, salts, and salts of isomers;
4 (48) PEPAP, 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine, its
5 optical isomers, salts, and salts of isomers;
6 (49) Acetyl-alpha-methylfentanyl, N-(1-(1-methyl-2-phenethyl)-4-
7 piperidinyl)-N-phenylacetamide, its optical isomers, salts, and salts of
8 isomers;
9 (50) Alpha-methylthiofentanyl, N-(1-methyl-2-(2-thienyl)ethyl-4-
10 piperidinyl)-N-phenylpropanamide, its optical isomers, salts, and salts
11 of isomers;
12 (51) Benzylfentanyl, N-(1-benzyl-4-piperidyl)-N-phenylpropanamide,
13 its optical isomers, salts, and salts of isomers;
14 (52) Beta-hydroxyfentanyl, N-(1-(2-hydroxy-2-phenethyl)-4-
15 piperidinyl)-N-phenylpropanamide, its optical isomers, salts, and salts
16 of isomers;
17 (53) Beta-hydroxy-3-methylfentanyl, (other name: N-(1-(2-hydroxy-2-
18 phenethyl)-3-methyl-4-piperidinyl)-N-phenylpropanamide), its optical and
19 geometric isomers, salts, and salts of isomers;
20 (54) 3-methylthiofentanyl, N-(3-methyl-1-(2-thienyl)ethyl-4-
21 piperidinyl)-N-phenylpropanamide, its optical and geometric isomers,
22 salts, and salts of isomers;
23 (55) N-(1-(2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide
24 (thenylfentanyl), its optical isomers, salts, and salts of isomers;
25 (56) Thiofentanyl, N-phenyl-N-(1-(2-thienyl)ethyl-4-piperidinyl)-
26 propanamide, its optical isomers, salts, and salts of isomers;
27 (57) Para-fluorofentanyl, N-(4-fluorophenyl)-N-(1-(2-phenethyl)-4-
28 piperidinyl)propanamide, its optical isomers, salts, and salts of
29 isomers;
30 (58) U-47700, 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-
31 methylbenzamide;
-4-
LB892 LB892
2024 2024
1 (59) 4-Fluoroisobutyryl Fentanyl;
2 (60) Acetyl Fentanyl;
3 (61) Acyrloylfentanyl;
4 (62) AH-7921; 3, 4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]
5 benzamide;
6 (63) Butyryl fentanyl;
7 (64) Cyclopentyl fentanyl;
8 (65) Cyclopropyl fentanyl;
9 (66) Furanyl fentanyl;
10 (67) Isobutyryl fentanyl;
11 (68) Isotonitazene;
12 (69) Methoxyacetyl fentanyl;
13 (70) MT-45; 1-cyclohexyl-4-(1,2-diphenylethyl) piperazine;
14 (71) Tetrahydrofuranyl fentanyl;
15 (72) 2-fluorofentanyl; N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-
16 yl) propionamide;
17 (73) Ocfentanil;
18 (74) Ortho-Fluorofentanyl;
19 (75) Para-chloroisobutyryl fentanyl;
20 (76) Para-Fluorobutyryl Fentanyl;
21 (77) Valeryl fentanyl;
22 (78) Phenyl Fentanyl;
23 (79) Para-Methylfentanyl;
24 (80) Thiofuranyl Fentanyl;
25 (81) Beta-methyl Fentanyl;
26 (82) Beta'-Phenyl Fentanyl;
27 (83) Crotonyl Fentanyl;
28 (84) 2'-Fluoro Ortho-Fluorofentanyl;
29 (85) 4'-Methyl Acetyl Fentanyl;
30 (86) Ortho-Fluorobutyryl Fentanyl;
31 (87) Ortho-Methyl Acetylfentanyl;
-5-
LB892 LB892
2024 2024
1 (88) Ortho-Methyl Methoxyacetyl Fentanyl;
2 (89) Ortho-Fluoroacryl Fentanyl;
3 (90) Fentanyl Carbamate;
4 (91) Ortho-Fluoroisobutyryl Fentanyl;
5 (92) Para-Fluoro Furanyl Fentanyl;
6 (93) Para-Methoxybutyryl Fentanyl;
7 (94) Brorphine (other name: 1-(1-(1-(4-bromophenyl) ethyl)
8 piperidin-4-yl-1,3-dihydro-2H-benzo[D]imidazole-2-one); and
9 (95) Fentanyl-related substances, their isomers, esters, ethers,
10 salts and salts of isomers, esters, and ethers. Unless specifically
11 excepted, listed in another schedule, or specifically named in this
12 schedule, this includes any substance that is structurally related to
13 fentanyl by one or more of the following modifications:
14 (A) Replacement of the phenyl portion of the phenethyl group by any
15 monocycle, whether or not further substituted in or on the monocycle;
16 (B) Substitution in or on the phenethyl group with alkyl, alkenyl,
17 alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;
18 (C) Substitution in or on the piperidine ring with alkyl, alkenyl,
19 alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups;
20 (D) Replacement of the aniline ring with any aromatic monocycle
21 whether or not further substituted in or on the aromatic monocycle; or
22 (E) Replacement of the N-propionyl group by another acyl group;
23 and .
24 (96) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-
25 benzimidazol-1-yl)ethan-1-amine).
26 (b) Any of the following opium derivatives, their salts, isomers,
27 and salts of isomers, unless specifically excepted, whenever the
28 existence of such salts, isomers, and salts of isomers is possible within
29 the specific chemical designation:
30 (1) Acetorphine;
31 (2) Acetyldihydrocodeine;
-6-
LB892 LB892
2024 2024
1 (3) Benzylmorphine;
2 (4) Codeine methylbromide;
3 (5) Codeine-N-Oxide;
4 (6) Cyprenorphine;
5 (7) Desomorphine;
6 (8) Dihydromorphine;
7 (9) Drotebanol;
8 (10) Etorphine, except hydrochloride salt;
9 (11) Heroin;
10 (12) Hydromorphinol;
11 (13) Methyldesorphine;
12 (14) Methyldihydromorphine;
13 (15) Morphine methylbromide;
14 (16) Morphine methylsulfonate;
15 (17) Morphine-N-Oxide;
16 (18) Myrophine;
17 (19) Nicocodeine;
18 (20) Nicomorphine;
19 (21) Normorphine;
20 (22) Pholcodine; and
21 (23) Thebacon.
22 (c) Any material, compound, mixture, or preparation which contains
23 any quantity of the following hallucinogenic substances, their salts,
24 isomers, and salts of isomers, unless specifically excepted, whenever the
25 existence of such salts, isomers, and salts of isomers is possible within
26 the specific chemical designation, and, for purposes of this subdivision
27 only, isomer shall include the optical, position, and geometric isomers:
28 (1) Bufotenine. Trade and other names shall include, but are not
29 limited to: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-
30 dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N,N-
31 dimethyltryptamine; and mappine;
-7-
LB892 LB892
2024 2024
1 (2) 4-bromo-2,5-dimethoxyamphetamine. Trade and other names shall
2 include, but are not limited to: 4-bromo-2,5-dimethoxy-alpha-
3 methylphenethylamine; and 4-bromo-2,5-DMA;
4 (3) 4-methoxyamphetamine. Trade and other names shall include, but
5 are not limited to: 4-methoxy-alpha-methylphenethylamine; and
6 paramethoxyamphetamine, PMA;
7 (4) 4-methyl-2,5-dimethoxyamphetamine. Trade and other names shall
8 include, but are not limited to: 4-methyl-2,5-dimethoxy-alpha-
9 methylphenethylamine; DOM; and STP;
10 (5) Para-methoxymethamphetamine. Trade and other names shall
11 include, but are not limited to: 1-(4-Methoxyphenyl)-N-methylpropan-2-
12 amine, PMMA, and 4-MMA;
13 (6) Ibogaine. Trade and other names shall include, but are not
14 limited to: 7-Ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-
15 methano-5H-pyrido (1',2':1,2) azepino (5,4-b) indole; and Tabernanthe
16 iboga;
17 (7) Lysergic acid diethylamide;
18 (8) Marijuana;
19 (9) Mescaline;
20 (10) Methoxetamine (MXE);
21 (11) Peyote. Peyote shall mean all parts of the plant presently
22 classified botanically as Lophophora williamsii Lemaire, whether growing
23 or not, the seeds thereof, any extract from any part of such plant, and
24 every compound, manufacture, salts, derivative, mixture, or preparation
25 of such plant or its seeds or extracts;
26 (12) Psilocybin;
27 (13) Psilocyn;
28 (14) Tetrahydrocannabinols, including, but not limited to, synthetic
29 equivalents of the substances contained in the plant or in the resinous
30 extractives of cannabis, sp. or synthetic substances, derivatives, and
31 their isomers with similar chemical structure and pharmacological
-8-
LB892 LB892
2024 2024
1 activity such as the following: Delta 1 cis or trans tetrahydrocannabinol
2 and their optical isomers, excluding dronabinol in a drug product
3 approved by the federal Food and Drug Administration; Delta 6 cis or
4 trans tetrahydrocannabinol and their optical isomers; and Delta 3,4 cis
5 or trans tetrahydrocannabinol and its optical isomers. Since nomenclature
6 of these substances is not internationally standardized, compounds of
7 these structures shall be included regardless of the numerical
8 designation of atomic positions covered. Tetrahydrocannabinols does not
9 include cannabidiol contained in a drug product approved by the federal
10 Food and Drug Administration;
11 (15) N-ethyl-3-piperidyl benzilate;
12 (16) N-methyl-3-piperidyl benzilate;
13 (17) Thiophene analog of phencyclidine. Trade and other names shall
14 include, but are not limited to: 1-(1-(2-thienyl)-cyclohexyl)-piperidine;
15 2-thienyl analog of phencyclidine; TPCP; and TCP;
16 (18) Hashish or concentrated cannabis;
17 (19) Parahexyl. Trade and other names shall include, but are not
18 limited to: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
19 dibenzo(b,d)pyran; and Synhexyl;
20 (20) Ethylamine analog of phencyclidine. Trade and other names shall
21 include, but are not limited to: N-ethyl-1-phenylcyclohexylamine; (1-
22 phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine;
23 cyclohexamine; and PCE;
24 (21) Pyrrolidine analog of phencyclidine. Trade and other names
25 shall include, but are not limited to: 1-(1-phenylcyclohexyl)-
26 pyrrolidine; PCPy; and PHP;
27 (22) Alpha-ethyltryptamine. Some trade or other names: etryptamine;
28 Monase; alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole;
29 alpha-ET; and AET;
30 (23) 2,5-dimethoxy-4-ethylamphet-amine; and DOET;
31 (24) 1-(1-(2-thienyl)cyclohexyl)pyrrolidine; and TCPy;
-9-
LB892 LB892
2024 2024
1 (25) Alpha-methyltryptamine, which is also known as AMT;
2 (26) Salvia divinorum or Salvinorin A. Salvia divinorum or
3 Salvinorin A includes all parts of the plant presently classified
4 botanically as Salvia divinorum, whether growing or not, the seeds
5 thereof, any extract from any part of such plant, and every compound,
6 manufacture, derivative, mixture, or preparation of such plant, its
7 seeds, or its extracts, including salts, isomers, and salts of isomers
8 whenever the existence of such salts, isomers, and salts of isomers is
9 possible within the specific chemical designation;
10 (27) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other
11 names: eutylone or bk-EBDB);
12 (28) (27) Any material, compound, mixture, or preparation containing
13 any quantity of synthetically produced cannabinoids as listed in
14 subdivisions (A) through (L) of this subdivision, including their salts,
15 isomers, salts of isomers, and nitrogen, oxygen, or sulfur-heterocyclic
16 analogs, unless specifically excepted elsewhere in this section. Since
17 nomenclature of these synthetically produced cannabinoids is not
18 internationally standardized a